title: Realities of the fluoxetine-to-sertraline switch.
authors.forename: T
authors.initials: T
authors.lastname: Schleis
mesh_terms: D015057:1-Naphthylamine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000191:economics; D003362:Cost-Benefit Analysis; D003863:Depression / Q000188:drug therapy; D005473:Fluoxetine / Q000008:administration & dosage* / Q000191:economics; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage* / Q000191:economics; D020280:Sertraline; D013607:Tablets
chemical_list: D015057:1-Naphthylamine; D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline; D013607:Tablets